Perpetua U Ibekwe, Dorra Bouazzi, Cecilia E Medianfar, Robin Christensen, Gregor B E Jemec
{"title":"尼日利亚阿布贾健康成人中化脓性汗腺炎的患病率。","authors":"Perpetua U Ibekwe, Dorra Bouazzi, Cecilia E Medianfar, Robin Christensen, Gregor B E Jemec","doi":"10.1159/000539443","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Hidradenitis suppurativa (HS) is an inflammatory disorder that affects the apocrine gland-bearing regions. There is currently no population-based study of HS in Nigeria. The purpose of this study was to investigate the prevalence of HS in Abuja, Nigeria's federal capital territory.</p><p><strong>Methods: </strong>This is a cross-sectional study of healthy adults accompanying patients to the outpatient clinics of the tertiary hospital in Abuja, utilizing the Global Hidradenitis Suppurativa Atlas (GHiSA) questionnaire as part of the GHiSA program.</p><p><strong>Results: </strong>The prevalence of HS in 898 participants was 3.3% (95% confidence interval (CI): 2.3%-4.7%). Participants with HS had a significantly higher body mass index than those without (p value of 0.038). One out of the 30 HS participants had a Hurley score of 2, while the rest had a Hurley score of 1. The majority of participants (49%) exhibited HS symptoms involving the axilla. The GHiSA questionnaire has a sensitivity rate of 93.8% (95% CI: 79.2%-97.3%) and a specificity rate of 93.8% (95% CI: 88.2%-97.3%).</p><p><strong>Conclusion: </strong>The prevalence of HS in our study (3.3%) was higher than that seen in hospital records (0.47%). This demonstrates that most HS patients present to the dermatology outpatient clinics when the disease is severe.</p>","PeriodicalId":11185,"journal":{"name":"Dermatology","volume":" ","pages":"1-5"},"PeriodicalIF":2.7000,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12233965/pdf/","citationCount":"0","resultStr":"{\"title\":\"Prevalence of Hidradenitis Suppurativa among Healthy Adults in Abuja, Nigeria.\",\"authors\":\"Perpetua U Ibekwe, Dorra Bouazzi, Cecilia E Medianfar, Robin Christensen, Gregor B E Jemec\",\"doi\":\"10.1159/000539443\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Hidradenitis suppurativa (HS) is an inflammatory disorder that affects the apocrine gland-bearing regions. There is currently no population-based study of HS in Nigeria. The purpose of this study was to investigate the prevalence of HS in Abuja, Nigeria's federal capital territory.</p><p><strong>Methods: </strong>This is a cross-sectional study of healthy adults accompanying patients to the outpatient clinics of the tertiary hospital in Abuja, utilizing the Global Hidradenitis Suppurativa Atlas (GHiSA) questionnaire as part of the GHiSA program.</p><p><strong>Results: </strong>The prevalence of HS in 898 participants was 3.3% (95% confidence interval (CI): 2.3%-4.7%). Participants with HS had a significantly higher body mass index than those without (p value of 0.038). One out of the 30 HS participants had a Hurley score of 2, while the rest had a Hurley score of 1. The majority of participants (49%) exhibited HS symptoms involving the axilla. The GHiSA questionnaire has a sensitivity rate of 93.8% (95% CI: 79.2%-97.3%) and a specificity rate of 93.8% (95% CI: 88.2%-97.3%).</p><p><strong>Conclusion: </strong>The prevalence of HS in our study (3.3%) was higher than that seen in hospital records (0.47%). This demonstrates that most HS patients present to the dermatology outpatient clinics when the disease is severe.</p>\",\"PeriodicalId\":11185,\"journal\":{\"name\":\"Dermatology\",\"volume\":\" \",\"pages\":\"1-5\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2025-07-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12233965/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Dermatology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1159/000539443\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"DERMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000539443","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"DERMATOLOGY","Score":null,"Total":0}
Prevalence of Hidradenitis Suppurativa among Healthy Adults in Abuja, Nigeria.
Introduction: Hidradenitis suppurativa (HS) is an inflammatory disorder that affects the apocrine gland-bearing regions. There is currently no population-based study of HS in Nigeria. The purpose of this study was to investigate the prevalence of HS in Abuja, Nigeria's federal capital territory.
Methods: This is a cross-sectional study of healthy adults accompanying patients to the outpatient clinics of the tertiary hospital in Abuja, utilizing the Global Hidradenitis Suppurativa Atlas (GHiSA) questionnaire as part of the GHiSA program.
Results: The prevalence of HS in 898 participants was 3.3% (95% confidence interval (CI): 2.3%-4.7%). Participants with HS had a significantly higher body mass index than those without (p value of 0.038). One out of the 30 HS participants had a Hurley score of 2, while the rest had a Hurley score of 1. The majority of participants (49%) exhibited HS symptoms involving the axilla. The GHiSA questionnaire has a sensitivity rate of 93.8% (95% CI: 79.2%-97.3%) and a specificity rate of 93.8% (95% CI: 88.2%-97.3%).
Conclusion: The prevalence of HS in our study (3.3%) was higher than that seen in hospital records (0.47%). This demonstrates that most HS patients present to the dermatology outpatient clinics when the disease is severe.
期刊介绍:
Published since 1893, ''Dermatology'' provides a worldwide survey of clinical and investigative dermatology. Original papers report clinical and laboratory findings. In order to inform readers of the implications of recent research, editorials and reviews prepared by invited, internationally recognized scientists are regularly featured. In addition to original papers, the journal publishes rapid communications, short communications, and letters to ''Dermatology''. ''Dermatology'' answers the complete information needs of practitioners concerned with progress in research related to skin, clinical dermatology and therapy. The journal enjoys a high scientific reputation with a continually increasing impact factor and an equally high circulation.